The Rise of GLP-1s in Sleep Apnea Treatment: Navigating Efficacy, FDA Approvals, and Insurance Complexities
The landscape of managing obstructive sleep apnea (OSA) is undergoing a significant transformation, driven in part by the increasing use of Glucagon-like peptide-1 receptor agonists (GLP-1s). These medications, initially developed…
